Efficacy of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: A systematic review and meta-analysis of randomized controlled trials

Xinrui Hu , Lijuan Qi , Jinbo Du , Yuhan Wang , Yukun Yin

Intelligent Pharmacy ›› 2026, Vol. 4 ›› Issue (4) : 297 -304.

PDF (2384KB)
Intelligent Pharmacy ›› 2026, Vol. 4 ›› Issue (4) :297 -304. DOI: 10.1016/j.ipha.2026.05.005
Review article
Efficacy of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: A systematic review and meta-analysis of randomized controlled trials
Author information +
History +
PDF (2384KB)

Abstract

Background: Breast cancer (BC) constitutes a significant global health challenge. Chemotherapy-induced nausea and vomiting (CINV) severely impact patient quality of life. Current antiemetics, while providing some relief, prove inadequate. Auricular acupressure (AA), originating from traditional Chinese medicine, demonstrates potential in managing CINV; yet, its efficacy and safety in the context of BC chemotherapy are still uncertain.

Methods: In compliance with PRISMA 2020 guidelines, we executed a systematic review and meta-analysis, searching PubMed, EMBASE, Cochrane CENTRAL,Web of Science, CNKI, and Wanfang until October 2023. We included randomized controlled trials (RCTs) that compared pure auricular acupressure (AA alone) or AA combined with consistent co-interventions across groups with standard care for BC patients and methodically performed data extraction, risk of bias evaluation, and meta-analysis. To ensure clear attribution of effect, subgroup analyses were performed between AA alone and AA plus other traditional Chinese medicine (TCM) interventions.

Results: Thirty-one RCTs involving 2522 participants, predominantly from China, satisfied our inclusion criteria. Notable heterogeneity was detected. Although AA did not markedly decrease acute or delayed vomiting, it significantly enhanced strictly defined complete response (score 0, no symptoms) rates for nausea (RR 1.31; 95% CI 1.16 – 1.47; P < 0.0001) and overall CINV (RR 1.79; 95% CI 1.60 – 2.00; P < 0.0001). Subgroup analysis confirmed that effects were consistent in both AA alone and AA combined with TCM, supporting that AA contributed independently to the improvement. Enhancements were more pronounced with prolonged treatment, higher frequency, and targeted use of specific auricular points.

Conclusions: AA may improve the comprehensive management of CINV, specifically nausea, not acute or delayed vomiting - among BC chemotherapy patients. The effect can be primarily attributed to auricular acupressure, as subgroup analysis ruled out confounding from combined TCM interventions. Nonetheless, given the methodological constraints, the reliability of this evidence is provisional. Comprehensive, large-scale RCTs are essential to verify these results.

Graphical abstract

Keywords

Breast cancer / Chemotherapy-induced nausea and vomiting / Auricular acupressure / Systematic review / Meta / Analysis

Cite this article

Download citation ▾
Xinrui Hu, Lijuan Qi, Jinbo Du, Yuhan Wang, Yukun Yin. Efficacy of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: A systematic review and meta-analysis of randomized controlled trials. Intelligent Pharmacy, 2026, 4 (4) : 297-304 DOI:10.1016/j.ipha.2026.05.005

登录浏览全文

4963

注册一个新账户 忘记密码

1 Introduction

Breast cancer (BC) constitutes a significant global health challenge, with more than 2.3 million new diagnoses and 685,000 associated fatalities in 2020.1 Contemporary therapeutic strategies for BC encompass surgical interventions, chemotherapy, radiotherapy, endocrine treatments, and targeted therapies.2

Chemotherapy-induced nausea and vomiting (CINV) constitutes a significant adverse effect in oncological therapy, profoundly affecting over 90% of breast cancer patients undergoing treatment with anthracycline, cyclophosphamide, and taxane.3,4 This syndrome drastically compromises quality of life,5 diminishes adherence to therapeutic protocols, and threatens clinical outcomes.6 Despite established protocols involving 5-hydroxytryptamine3 (5-HT3) and neurokinin 1 (NK-1) receptor antagonists, corticosteroids, and olanzapine,7,8 nearly 40% of patients continue to endure persistent CINV.9 Consequently, the formulation of comprehensive, multidisciplinary strategies to improve CINV prophylaxis is imperative to address this pervasive clinical issue.

Auricular acupressure (AA), an established traditional Chinese medicine modality, involves affixing medicinal seeds or magnetic pellets to specific auricular acupoints and systematically administering kneading, pinching, and pressing. This approach generates sensations of heat, numbness, distension, and pain, thereby eliciting a therapeutic effect.10 Acupressure, a non-invasive intervention for nausea and vomiting, offers effects comparable to acupuncture and can be applied across various body parts.11 Additionally, auriculotherapy, or AA, ranks among the most prevalent microsystems in Eastern medicine. A clinical trial on CINV in breast cancer patients found that both actual and placebo AA treatments resulted in a lower incidence and severity of acute CINV than standard care, with significant differences in the occurrence (p = 0.04) and severity (p = 0.001) of acute nausea.12

A recent meta-analysis demonstrated that acupuncture surpasses traditional care in controlling both acute and delayed CINV13; however, the validity of this evidence is compromised by its failure to distinguish among different tumor types or chemotherapy protocols. Significantly, the influence of auricular acupoint therapy on CINV, particularly within breast cancer therapies, remains inadequately explored in existing meta-analyses. The efficacy and safety of AA in managing CINV in breast cancer patients are yet to be substantiated. Consequently, synthesizing current clinical research with comprehensive meta-analyses might substantiate AA's therapeutic advantages and safety for CINV. Comprehensive investigations into AA's effectiveness in treating CINV among breast cancer patients have not yet been conducted.

2 Methods

2.1 Literature search

This study adhered to PRISMA 2020 guidelines14 and was proactively registered with PROSPERO (CRD2024523835). This systematic review and meta-analysis fully complies with the pre-registered PROSPERO protocol, with complete consistency in research objects, intervention measures, outcome indicators and retrieval time. We conducted a comprehensive search of PubMed, EMBASE, Cochrane CENTRAL, Web of Science, China National Knowledge Infrastructure, and Wanfang databases through October 2023, which is completely consistent with the retrieval deadline set in the registration plan, assessing the effectiveness of auricular acupressure compared to standard care in alleviating chemotherapy-induced nausea and vomiting among breast cancer patients, irrespective of language. Key search terms included: “breast neoplasms”, “breast cancer”, “human mammary carcinomas”, “auricular acupressure”, “nausea”, “vomiting”, and “emesis”. The search strategy is outlined in Table 1. Additionally, we conducted a manual review of the reference lists from selected studies. Two investigators independently executed and assessed the searches. Any discrepancies were addressed through consensus-based deliberations.

2.2 Eligibility criteria

Randomized controlled trials (RCTs) assessing AA against sham or standard care were selected for inclusion. AA was defined as the stimulation of specific auricular acupoints using medicinal seeds or magnetic pellets with pressing/kneading manipulations. Studies were included only if co-interventions (e.g., antiemetic therapy, other TCM methods) were applied identically in both intervention and control groups, so that any between-group difference could be attributed to AA. Permitted co-interventions, such as antiemetic therapy, required uniformity across all trial arms. Eligibility was confined to adults diagnosed with breast cancer, slated for chemotherapy, and devoid of prior nausea or vomiting. Exclusions encompassed reviews, letters, editorial comments, case reports, conference abstracts, pediatric studies, unpublished manuscripts, and studies in which additional TCM interventions were applied only in the AA group but not in controls (to avoid confounding attribution).

2.3 Data extraction, and quality assessment

Authors Xinrui Hu and Jinbo Du independently screened references and evaluated the full texts based on inclusion criteria after identifying potentially eligible records. We extracted pertinent data such as first author, publication year, study period, country, study design, demographic profile, sample size, age, intervention details, control measures, efficacy criteria, follow-up duration, and therapeutic outcomes from these studies. We conducted a quality assessment of eligible RCTs using seven criteria specified in the Cochrane Handbook for Systematic Reviews of Interventions 5.1.0: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessments, management of incomplete outcome data, selective reporting, and other potential biases.15 Each study aspect was assigned a risk evaluation-low, high, or unclear—with studies predominantly categorized as low risk deemed to be of higher quality. Any discrepancies in the assessment of quality and evidence levels were resolved through discussions between the two investigators.

2.4 Data analysis and synthesis of results

Evidence synthesis was performed using Review Manager 5.4 (Cochrane Collaboration, Oxford, UK). This meta-analysis evaluated the therapeutic effects of auricular acupressure, expressed as relative risks (RRs), with RRs exceeding 1.0 indicating superior management of CINV. Analysis was based on available cases from the intention-to-treat population. Statistical aggregation was conducted when there was homogeneity among comparison groups, outcomes, and CINV phases. Heterogeneity of the studies was determined using the chi-squared (χ2) test (Cochran's Q) and the inconsistency index (I2),16 with a χ2 p-value less than 0.05 or I2 greater than 50% denoting significant heterogeneity. To address potential confounding from combined interventions, a prespecified subgroup analysis was conducted to compare efficacy between: AA used as monotherapy; AA combined with other TCM interventions (with identical co-interventions in controls). One-way sensitivity analyses probed the impact of including studies on the synthesized outcomes for notably heterogeneous results. Publication bias was visually assessed with funnel plots. Egger's regression tests in Stata 15.1 were performed only for only for the overall CINV outcome (21 studies, ≥ 10 studies) to ensure reliability.17 For outcomes with fewer than 10 studies, only visual funnel plot assessment was used. A P-value less than 0.05 was deemed indicative of significant publication bias. Complete control of vomiting and/or nausea was defined according to the WHO antiemetic side effect rating criteria (96.8%, n = 30). In line with most original studies, nausea and vomiting were rated on a 0 – 4 scale18: 0 = no symptom, 1 = mild symptom, no intervention needed, 2 = moderate symptom, 3 = severe symptom, 4 = very severe symptom. For meta-analysis consistency, we used the strict definition of complete response (CR): score = 0 (no nausea, no vomiting, no rescue medication). Studies that defined scores 0 – 1 as “effective control” were reclassified to the strict 0-score CR to avoid overestimation. Dichotomization (complete response vs. non-complete response) was performed strictly according to the outcome definition reported in each original trial. When studies used a 0 – 4 scale and defined scores 0 – 1 as “controlled”, we recorded this definition clearly and stated it as the study's own endpoint, without over-interpretation as strict “complete response”in the traditional sense. The outcome indicators selected for this analysis (complete response of acute vomiting, delayed vomiting, nausea and overall CINV) are completely consistent with the core outcome settings in the registration protocol. When data allowed, we investigated the effect of integrating auricular acupressure with other Chinese medicine practices, selection of auricular points, and frequency of application on CINV effectiveness, conducting subgroup analyses where three or more studies were available.

3 Results

3.1 Literature search and study characteristics

The systematic search and selection process, outlined in Fig. 1, yielded 81 pertinent articles from comprehensive searches conducted in PubMed (n = 4), Embase (n = 5), Cochrane (n = 3), Web of Science (n = 5), China National Knowledge Infrastructure (n = 26), and Wanfang (n = 38). Following the removal of duplicates, we evaluated 50 titles and abstracts. Subsequently, 31 full-text articles encompassing 2,522 patients (1,261 non-AA and 1,261 AA) were incorporated into the pooled analysis 12,19–48. These studies, all RCTs, specifically explored auricular acupressure in breast cancer patients. Appendix 1 elaborates on the characteristics, study design, and research data of each included study.

In the 31 RCTs, auricular acupressure was administered either as monotherapy or in conjunction with other TCM methods (including acupoint application, supplementary acupuncture, or oral Chinese medicine) to manage CINV. Crucially, all co-interventions were applied equally in both experimental and control groups in the included studies, so that group differences could be reliably attributed to AA. These interventions were evaluated against conventional treatments, placebo, or no treatment. Among these studies, 94% (n = 29) were conducted in China, with one study each in Brazil and Iran. Seventeen auricular acupoints, utilized for CINV, are illustrated in Fig. 2, with annotations denoting their frequency of use. The Stomach, sympathetic, and Shenmen points were predominantly selected. A single study incorporated a sham control, which likely facilitated patient blinding. The tools for measuring CINV outcomes varied; 28 studies (90.3%) reported dichotomous outcomes (patients without nausea/vomiting), while three studies (9.7%) provided continuous outcomes (mean/median nausea/vomiting scores). Owing to the diverse nature of data reporting, only the dichotomous data from 28 studies were amenable to meta-analysis.

3.2 Risk of bias

The bias risk assessment for the included studies is detailed in Figs. 3 and 4. All 31 studies were reported as “randomized”; however, 26 studies (83.9%) provided no details on random sequence generation and were rated as unclear risk of selection bias. Only 5 studies provided adequate information and were rated as low risk. Only four studies (12.9%) clearly implemented allocation concealment, leaving the procedure ambiguous in the remaining 27 studies (87.1%), resulting in an unclear risk of bias. The integrity of blinding was questionable in two studies (6.5%), potentially compromised by interactions with the acupuncturists despite the use of sham controls. A significant risk of performance and detection biases was identified in 93.5% of the studies. Attrition bias was minimal in five studies (16.1%), yet remained indeterminate in 26 others (83.9%). The risk of biased outcome reporting was deemed low in 22 studies (71.0%).

3.3 Effects for complete control of CINV

Complete response (CR) was strictly defined as score 0 (no symptoms, no rescue medication).

3.3.1 Complete response of acute vomiting

For acute CINV, the AA group demonstrated no statistically significant difference in the complete response rate for acute vomiting compared with the control group (RR = 1.20; 95% CI: 0.97–1.49; p = 0.09; I2 = 67%; 5 studies, 385 patients; see Fig. 5A). Funnel plot visualization showed no obvious asymmetry, suggesting no evident publication bias; Egger's test was not performed due to the small number of studies (n = 5) (see Fig. 6).

3.3.2 Complete response of delayed vomiting

For delayed CINV, the complete response rate for delayed vomiting did not differ significantly between the AA and control groups (RR = 1.20; 95% CI: 0.97–1.49; p = 0.10; I2 = 75%; 5 studies, 385 patients; see Fig. 5B). Funnel plot visualization indicated no apparent publication bias; Egger's test was not performed due to the small number of studies (n = 5).

3.3.3 Complete response of nausea

A significant difference in the complete response rate for nausea was identified between the AA and control groups (RR = 1.31; 95% CI: 1.16–1.47; p < 0.00001; I2 = 10%; 8 studies, 679 patients; see Fig. 5C). Funnel plot visualization indicated no evidence of publication bias; Egger's test was not performed due to the small number of studies (n = 8).

3.3.4 Complete response of CINV

A significant difference in the complete response rate for CINV was observed between the AA and control groups (RR = 1.79; 95% CI: 1.60–2.00; p < 0.00001; I2 = 37%; 21 studies, 1,759 patients; see Fig. 5D). Funnel plot analysis suggested mild asymmetry, and Egger's test was statistically significant (p = 0.019), indicating potential publication bias for this outcome.

3.3.5 Subgroup analysis of auricular acupressure for complete response of CINV

Subgroup analysis was performed to clarify whether effects were driven by AA alone or by combined TCM interventions. In the subgroup analysis of CINV and nausea, AA exhibited consistent effects across AA monotherapy and AA plus other TCM subgroups (Table 1). Although it appeared to improve the complete response to acute vomiting in the ≤ 3 times per day subgroup, the finding was derived from a single study and lacked sufficient evidence to support generalization. The consistent benefit in both subgroups confirms that auricular acupressure itself contributed to the improved CINV control, rather than confounding co-interventions.

4 Discussion

Functional MRI studies have demonstrated that acupressure and acupuncture modulate both cortical and subcortical activity within the limbic system and other brain regions.49 As a microsystem applied to the external ear, AA similarly promotes endogenous opioid release and is believed to share physiological mechanisms with somatic acupressure.50 Stimulation of specific auricular points using needles, granules, electrical impulses, or their combination has been associated with symptom relief in a broad range of conditions, including acute and chronic pain, psychological disorders (e.g., anxiety, depression, attention deficit), dizziness, nicotine dependence, inflammation, endocrine and urinary dysfunction, infections, obesity, and nausea.32 Based on this evidence, we conducted the most comprehensive systematic review and meta-analysis to date, integrating data from 31 comparative studies involving 2,522 patients. Our findings suggest that AA combined with standard care may improve complete responses to CINV compared with standard care alone, although no significant effects were observed for chemotherapy-induced acute or delayed vomiting.

The findings for complete responses to CINV indicated significantly greater efficacy in the AA group, suggesting that AA may offer therapeutic benefits for managing chemotherapy-induced CINV in breast cancer patients. However, its effects on nausea and vomiting remained inconsistent. Delayed emesis, typically occurring 24 h after administration of agents such as cisplatin, carboplatin, cyclophosphamide, or doxorubicin, is mediated by substance P activation of neurokinin-1 receptors in both the central and peripheral nervous systems. In contrast, acute CINV arises within 1 to 6 h post-chemotherapy and generally resolves within 24 h, primarily involving selective stimulation of 5-HT3 receptors. Compared with acute CINV, delayed CINV is more prevalent and less responsive to standard prophylactic antiemetic therapies.51 The observed heterogeneity may result from limited sample sizes and biases associated with patient self-reports and assessor evaluations. Nausea, characterized by a dynamic threshold, is modulated by both intrinsic and psychological factors.13 Although commonly triggered by similar stimuli, nausea and vomiting are distinct physiological processes involving both shared and discrete mechanisms.52 Nausea is generally more difficult to manage than vomiting and is less frequently assessed in clinical research,53 a trend also evident in the trials included in this analysis. This discrepancy may stem from the inherent challenges in measuring nausea. As a subjective symptom, it depends on patient self-reporting, which can introduce bias-particularly in unblinded studies or when blinding is compromised through interaction with the acupressurist. Moreover, none of the included studies reported retching as a distinct outcome from nausea or vomiting, and patients may misclassify other gastrointestinal symptoms as nausea. Employing a validated, nausea-specific, and user-friendly questionnaire could improve the assessment of CINV and enhance the reliability of clinical data.54

A meta-analysis reported that acupuncture-point stimulation significantly reduced the incidence of acute vomiting (RR = 0.82; 95% CI: 0.69–0.99; p = 0.04). Acupressure also lowered the mean severity and peak intensity of acute nausea, although it had no significant effect on acute vomiting or delayed symptoms (standardized mean difference = 0.19; 95% CI: 0.38–0.01; p = 0.03).55 Another meta-analysis indicated that acupuncture may enhance complete control of both acute (RR = 1.13; 95% CI: 1.02–1.25) and delayed vomiting (RR = 1.47; 95% CI: 1.07–2.00; 10 studies each).13 These results suggest that acupuncture is more effective for chemotherapy-induced vomiting than for nausea. Consistent with our findings, acupressure appears more effective in alleviating nausea than vomiting. The differential effects and underlying mechanisms of acupuncture and acupressure in the management of CINV warrant further investigation.

Our review identified 17 auricular acupoints, primarily utilized to alleviate gastric discomfort. The most frequently applied were the stomach, sympathetic, Shenmen, and spleen points. The stomach point is associated with reduced nausea and enhanced gastrointestinal function.36 The Shenmen point, located in the triangular fossa at the junction of the middle and lower thirds of the line connecting the hypotensive and pelvic points, is believed to modulate cerebral excitability and inhibition. It also exerts analgesic, sedative, and anti-inflammatory effects and is frequently employed clinically for its calming and analgesic properties.56 The sympathetic point alleviates visceral spasms, provides analgesia for internal organs, and mitigates nausea and vomiting induced by vagal stimulation.30 The spleen point, often activated via ear seeds, is thought to regulate the lung, spleen, and stomach meridians and facilitate qi circulation.37 These four principal auricular points for managing CINV may offer valuable guidance for clinical application. Nevertheless, in contrast to acupuncture, the mechanisms underlying auricular therapy remain inadequately understood and warrant further investigation.

Subgroup analysis revealed auricular acupressure alone was comparably effective to its combination with other TCM modalities in managing CINV. This consistency rules out confounding by co-interventions and confirms that the observed benefit can be primarily attributed to auricular acupressure. Possible minor heterogeneity may arise from variations in TCM protocols across studies. Irrespective of combination, auricular acupoints consistently exhibited notable efficacy in alleviating CINV. Improved outcomes were associated with treatment durations of at least one week and frequencies exceeding three sessions per day. In contrast, for nausea, combined TCM interventions demonstrated superior efficacy compared to auricular acupoints alone. Interestingly, shorter treatment durations (< 1 week) and lower frequencies (≤ 3 sessions/day) were linked to better outcomes, likely attributable to limited sample sizes and the subjective nature of nausea assessment. For acute vomiting, the subgroup with ≦ 3 times/day included only one study; no reliable conclusion can be drawn. No significant differences were found between acute and delayed vomiting. Overall, auricular acupoint therapy proved effective for CINV, with extended treatment durations and broader acupoint selection offering enhanced benefits for CINV control.

The overall sample size of the included studies was limited, with an evident absence of large-scale cohort investigations. Publications based on small samples are more prone to selection bias. The majority of participants were from China, resulting in a lack of robust clinical data from other regions. The evaluation of nausea remains less reliable due to subjective variability and the multifactorial nature of the condition. Notably, this study represents the most up-to-date meta-analysis with the largest aggregated sample examining auricular acupoint therapy for CINV in breast cancer patients. It systematically assessed the methodological quality of the included studies from multiple dimensions. The findings reinforce the therapeutic potential of auricular acupoint therapy for CINV in this patient population. As a non-invasive, externally applied modality, it provides a safer alternative to conventional interventions. To date, documented adverse effects remain minimal.

5 Conclusion

Auricular acupressure may improve strictly defined complete response (0 score, no symptoms) of CINV, particularly nausea, without significant benefit for acute or delayed vomiting. The effect can be reliably attributed to auricular acupressure, as subgroup analysis confirmed consistent benefit regardless of combined TCM interventions, and all co-interventions were balanced across groups. To substantiate these findings, well-designed confirmatory studies with larger sample sizes, standardized protocols, and defined core outcomes are necessary.

References

[1]

Yap YS. Outcomes in breast cancer-does ethnicity matter? ESMO Open. 2023;8:101564.

[2]

Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134–1150.

[3]

Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374:1356–1367.

[4]

Kerr AJ, et al. Adjuvant and neoadjuvant breast cancer treatments: a systematic review of their effects on mortality. Cancer Treat Rev. 2022;105:102375.

[5]

Razvi Y, et al. ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer. 2019;27:87–95.

[6]

Aapro M, et al. Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: results of the nausea/emesis registry in oncology (NERO). Eur J Cancer. 2022;166:126–133.

[7]

Sherani F, Boston C, Mba N. Latest update on prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients. Curr Oncol Rep. 2019;21:89.

[8]

Navari RM, et al. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;375:134–142.

[9]

Aapro M. CINV: still troubling patients after all these years. Support Care Cancer. 2018;26:5–9.

[10]

Yang T, et al. Efficacy of auricular acupressure in maintenance haemodialysis patients: a systematic review and meta-analysis. J Clin Nurs. 2022;31:508–519.

[11]

Waits A, Tang YR, Cheng HM, Tai CJ, Chien LY. Acupressure effect on sleep quality: a systematic review and meta-analysis. Sleep Med Rev. 2018;37:24–34.

[12]

Tan JY, et al. Effects of auricular acupressure on chemotherapy-induced nausea and vomiting in breast cancer patients: a preliminary randomized controlled trial. BMC Complement Med Ther. 2022;22:87.

[13]

Yan Y, et al. Acupuncture for the prevention of chemotherapy-induced nausea and vomiting in cancer patients: a systematic review and meta-analysis. Cancer Med. 2023;12:12504–12517.

[14]

Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

[15]

Cumpston M, et al. Updated guidance for trusted systematic reviews: a new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142.

[16]

Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: q statistic or I2 index? Psychol Methods. 2006;11:193–206.

[17]

Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Res ed). 1997;315(7109):629–634.

[18]

Hesketh PJ, et al. Antiemetics: American society of clinical oncology clinical practice guideline update. J Clin Oncol : offi J Am Soc Clin Oncol. 2017;35:3240–3261.

[19]

Liu H, Yang P, Ding Y, Du R, Yu Y. Application Effect of Embedding Beans in Auricular Point in Chemotherapy Nursing of Breast Cancer Patients Clinical Research and Practice. 4. 2019:171–173.

[20]

Wu T, Li J. Application effect of auricular point pressure combined with acupoint moxibustion on preventing delayed vomiting in patients with breast cancer chemotherapy Chinese and foreign medical research. 2021;19:155–157.

[21]

Liao H, Fu X, Zhu X, Liang K. Application of auricular point compression bean combined with nano acupoint application in palliative treatment of breast cancer. Guangdong Med J. 2017;38:1607–1609.

[22]

Aguiar Vallim ET, et al. Auricular acupressure in the quality of life of women with breast cancer: a randomized clinical trial. Rev Esc Enferm USP. 2019;53.

[23]

Cai X. Auricular point sticking improves the effect of nausea and vomiting after chemotherapy for breast cancer. Med Prev. 2013:334–335.

[24]

Qin H, Ma S, Jiang L. Auricular point sticking combined with acupoint massage for prevention and treatment of nausea and vomiting after chemotherapy for breast cancer surgery: 30 cases journal of emergency in traditional Chinese medicine. 2011;20(1955):1965.

[25]

Shi D, Wang X, Wu L, Li C. Clinical effect of embedding beans in auricular point combined with acupoint massage on nausea and vomiting caused by chemotherapy for breast cancer. Healthmust-Readmagazine. 2021;50–51.

[26]

Liang L, Mo C, Li J, Kong Z, Hong Q. Clinical observation of auricular point combined with acupoint application in treatment of vomiting caused by chemotherapy for breast cancer. J New Chin Med. 2018;50:116–119.

[27]

Lin S. Clinical observation on treating nausea and vomiting after chemotherapy of breast cancer by oral administration of auricular point pressing dou combined with Xuanfudaizhe decoction clinical journal of Chinese medicine. 2019;11:114–115.

[28]

Yang R. Clinical observation of auricular point compression and ondansetron in the treatment of nausea and vomiting after chemotherapy for breast cancer. Shanxi Acad Tradition Chin Med. 2018;34:45–46.

[29]

Yun Y. Clinical observation of 30 cases of chemotherapeutic vomiting treated by combination of Chinese and Western medicine. Jiangsu J Tradition Chin Med. 2009;41:36.

[30]

Wu S, Shao Z, Wu Y. Clinical study on gastrointestinal side effects of postoperative chemotherapy in patients with breast cancer treated by combination of traditional Chinese and Western medicine. Modern Tradition Chin Med. 2018;38:73–75.

[31]

Ye R, Wang S, Chen B. Clinical study on embedding acupuncture at auricular point in treatment of nausea and vomiting caused by chemotherapy for breast cancer Asia-Pacific traditional medicine. 2017;13:139–141.

[32]

Eghbali M, et al. The effect of auricular acupressure on nausea and vomiting caused by chemotherapy among breast cancer patients. Compl Ther Clin Pract. 2016;24:189–194.

[33]

Song J. Effect of Auricular Point Compression on Alleviating Nausea and Vomiting in Breast Cancer Patients After Chemotherapy China Higher Medical Education. 2015:126–127.

[34]

Zhang M, Zuo Y, Sun L. Effect of auricular point seeding on gastrointestinal reaction induced by chemotherapy in postoperative breast cancer patients. J Qilu Nursing. 2015;21, 124, 123.

[35]

Hu Y. Observation on effect of embedding beans in auricular point combined with acupoint massage on preventing nausea and vomiting in breast cancer patients after chemotherapy. Today Nurse. 2016;23:56–58.

[36]

Wang Y, Wu J, Chen P. Observation on the curative effect of auricular point compression and acupoint application on nausea and vomiting caused by chemotherapy. J Guangzhou Univ Tradition Chin Med. 2019;36:1018–1022.

[37]

Song Z. Study on the Effect of Ear-point Pressure Dou plus Shenque Point in the Treatment of Nausea, Vomiting and Constipation in Breast Cancer Patients After Chemotherapy, Shandong Traditional Chinese Medicine University. 2020.

[38]

Lu A, Liu L. Observation on effect of embedding beans in auricular point to prevent vomiting from chemotherapy for breast cancer. Guangming J Chin Med. 2016;31:1297–1298.

[39]

Zhang Y, Ji F, Sun L, Jin L. Observation of therapeutic effect on preventing nausea and vomiting caused by chemotherapy in 40 cases of breast cancer. Chin J Tradition Med Sci Technol. 2013;20:134.

[40]

Wang Y. Observation on the efficacy of embedding seed in auricular point for adjuvant treatment of nausea and vomiting after chemotherapy for breast cancer. Jilin Med J. 2012;33:2268–2269.

[41]

Zhou Y. Observation on effect of embedding seed in auricular point combined with acupoint application in adjuvant treatment of nausea and vomiting after chemotherapy for breast cancer. Today Nurse. 2018;25:111–112.

[42]

Zhang S, Cai L. Effect of auricular point seeding combined with palonosetron hydrochloride on prevention and treatment of nausea and vomiting in patients with postoperative chemotherapy for breast cancer. Today Nurse. 2020;27:96–97.

[43]

Hong R, Chen X, Hu C. Observation on curative effect of auricular point sticking on preventing vomiting during chemotherapy of breast cancer. Shanghai J Acupunct Moxibustion. 2014;33:516–517.

[44]

Li X, Wang C, Ji Y. Observation on curative effect of auricular point sticking combined with acupuncture on treating nausea and vomiting caused by chemotherapy after breast cancer surgery. Hebei J Tradition Chin Med. 2020;42:917–921.

[45]

Lu Y. Observation on the effect of auricular acupressure on preventing nausea and vomiting after chemotherapy for breast cancer. Shandong J Tradit Chin Med. 2012;31:42–43.

[46]

Li L, Yang M, Chen J. Observation on the effect of auricular point compression on preventing nausea and vomiting after chemotherapy for breast cancer. Health Guide. 2018;45:196.

[47]

Zhao S. Evaluation of intervention effect of acupuncture and auricular point sticking on digestive tract response during postoperative chemotherapy for breast cancer. Special Health. 2022;18:109–111.

[48]

Peng M, Wei J. Observation of curative effect of acupoint therapy on nausea and vomiting caused by chemotherapy for breast cancer. Chine General Pract Nurs. 2013;34:3214–3215.

[49]

Shah AN, Moore CB, Brigger MT. Auricular acupuncture for adult tonsillectomy. Laryngoscope. 2020;130:1907–1912.

[50]

Moura CC, et al. Effects of ear acupuncture combined with cupping therapy on severity and threshold of chronic back pain and physical disability: a randomized clinical trial. J Tradit Complement Med. 2022;12:152–161.

[51]

Janicki PK. Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant-palonosetron combination. Therapeut Clin Risk Manag. 2016;12:693–699.

[52]

Wickham RJ. Nausea and vomiting: a palliative care imperative. Curr Oncol Rep. 2020;22(1).

[53]

Crowder SL, et al. Metagenomics and chemotherapy-induced nausea: a roadmap for future research. Cancer. 2022;128:461–470.

[54]

Kenward H, Pelligand L, Savary-Bataille K, Elliott J. Nausea: current knowledge of mechanisms, measurement and clinical impact. Vet J. 2015;203:36–43.

[55]

Ezzo J, et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol : offi J Am Soc Clin Oncol. 2005;23:7188–7198.

[56]

Huang YP, Zhong YX, Tian XD, Dong S. An auricular acupoint comprehensive manipulation technique for the treatment of hordeolum: a case study. Asian J Surg. 2024;47:801–803.

Rights & permissions

2026 Publishing services by Elsevier B.V. on behalf of Higher Education Press and KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PDF (2384KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉